Wide dissemination of extended-spectrum ß-lactamase-producing Escherichia coli in community residents in the indochinese peninsula

Infection and Drug Resistance

Volumn 8, Issue , 2015, Pages 1-5

  Nakayama, Tatsuya ^a   Ueda, Shuhei ^b   Huong, Bui Thi Mai ^c   Tuyen, Le Danh ^c   Komalamisra, Chalit ^d   Kusolsuk, Teera ^d   Hirai, Itaru ^b   Yamamoto, Yoshimasa ^a,e  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c Institute of Nutrition   (Viet Nam)

^d MAHIDOL UNIVERSITY   (Thailand)

^e OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Extended spectrum P lactamase (ESBL); Fecal carriage; Indochinese peninsula; Rural residents

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL DISSEMINATION; BACTERIAL GENE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMMUNITY; CTX M GENE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENOTYPE; HUMAN; LAOS; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHYLOGENY; PREVALENCE; RURAL POPULATION; THAILAND; VIET NAM;

EID: 84921989695     PISSN: 11786973     EISSN: 11786973     Source Type: Journal    
DOI: 10.2147/IDR.S74934     Document Type: Article

References (24)

1. Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D. A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011. Pharmaceuticals (Basel). 2013;6(11):1335-1346.
2. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. JHosp Infect. 2009;73(4): 345-354.
3. Sasaki T, Hirai I, Niki M, et al. High prevalence of CTX-M beta-lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J Antimicrob Chemother. 2010;65(4):666-668.
4. Luvsansharav UO, Hirai I, Niki M, et al. Analysis of risk factors for a high prevalence of extended-spectrum (beta)-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand. J Med Microbiol. 2011;60(5):619-624.
5. Hsueh PR, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect. 2011;63(2):114-123.
6. Tian SF, Chen BY, Chu YZ, Wang S. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China. Can J Microbiol. 2008;54(9):781-785.
7. Cockerill FR. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI: PA, USA; 2011.
8. jlindquist.net [homepage on the Internet]. University of Wisconsin-Madison Microbiology. Available from: http://www.jlindquist.net/generalmicro/102bactid.html. Accessed October 20, 2014.
9. Luvsansharav UO, Hirai I, Nakata A, et al. Prevalence of and risk factors associated with faecal carriage of CTX-M beta-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother. 2012;67(7):1769-1774.
10. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol. 2004;42(12):5715-5721.
11. Luvsansharav UO, Hirai I, Niki M, et al. Prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobac-teriaceae among healthy adult people in Japan. J Infect Chemother. 2011;17(5):722-725.
12. Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended Spectrum Beta-lactamases: Definition, Classification and Epidemiology. Curr Issues Mol Biol. 2014;17:11-22.
13. Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42(3):1089-1094.
14. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother. 2004;48(1):1-14.
15. Lascols C, Hackel M, Hujer AM, et al. Using nucleic acid microarrays to perform molecular epidemiology and detect novel beta-lactamases: a snapshot of extended-spectrum beta-lactamases throughout the world. J Clin Microbiol. 2012;50(5):1632-1639.
16. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5(8):481-493.
17. Tamang MD, Nam HM, Gurung M, et al. Molecular characterization of CTX-M beta-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment. ApplEnviron Microbiol. 2013;79(13):3898-3905.
18. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother. 2011;66(1):1-14.
19. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47).
20. Li B, Sun JY, Liu QZ, Han LZ, Huang XH, Ni YX. High prevalence of CTX-M beta-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis. 2011;43(3):170-174.
21. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010;8(3):207-217.
22. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother. 2009;53(7):2846-2851.
23. Coque TM, Novais A, Carattoli A, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis. 2008;14(2):195-200.
24. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35(4):316-321.